- ICH GCP
- US-Register für klinische Studien
- Klinische Studie NCT07565636
3D Printed Orthosis for Wrist Instability for Ehlers-Danlos Syndrome Patient
Custom Orthotic Using 3D Printed and 3D Scanned Method
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
The purpose of this study is to examine the impact that a 3D-scanned and 3D-printed forearm wrist and hand orthosis has on function, pain and quality of life for people with Ehlers-Danlos Syndrome.
The goal of this research is to create a more supportive wrist hand orthosis for people with Ehlers-Danlos Syndrome (EDS) to prevent wrist dislocation using 3D scanning and 3D printing technologies with a biomedically safe material and address concerns for an underserved medical population. The investigators' goal is to create an orthosis that works better than the traditional ones by providing more support and decreasing pain for the participants with EDS. The investigators will create a custom 3D scanned and 3D printed wrist-hand orthotic for the participant and evaluate if there is a change on number of subluxation/dislocation due to Ehlers- Danlos syndrome as it relates to pain, activity participation and patient satisfaction. To assess this, the investigators will use patient-rated outcome measures, such as: the 0-100 Pain Scale, daily # of subluxation/dislocation occurrences, activity level via Health Assessment Questionnaire HAQ-D1, and the OPUS Satisfaction with Device and Services survey.
Aim 1: Develop a custom 3D-printed wrist-hand orthosis for participants with Ehlers-Danlos Syndrome (EDS) using 3D scanning and printing technologies.
The investigators will design and fabricate a custom orthosis tailored to each participant's unique anatomical needs using biomedically safe materials. The aim is to create an orthotic device that provides enhanced support to the wrist and hand, preventing subluxation and dislocation while minimizing pain compared to pre-fabricated orthoses.
Aim 2: Evaluate the effectiveness of the custom 3D-printed orthosis in changing the number of wrist subluxation/dislocation and changing the pain levels in participants with EDS.
The investigators will assess the effectiveness of the wrist-hand orthosis by measuring the frequency of subluxation/dislocation events and evaluating pain levels before and after wearing the device. The 0-100 Pain Scale will be used to quantify pain relief, and the occurrence of wrist subluxation/dislocation will be recorded to determine the device's impact on joint stability.
Aim 3: Assess the impact of the custom 3D-printed orthosis on activity participation and overall functional status in individuals with EDS.
The investigators will measure changes in activity levels and functional status using patient-reported outcome measures, including the Health Assessment Questionnaire HAQ-DI, and OPUS Satisfaction with Device and Services. These metrics will provide insight into the orthosis's ability to enhance participation in daily activities and improve overall quality of life for individuals with EDS.
Aim 4: Measure participant satisfaction with the custom 3D-printed orthosis. The investigators will use the OPUS Satisfaction with Device and Services survey to evaluate patient satisfaction with the orthosis. This will help determine whether the 3D-printed orthosis meets the unique needs and preferences of individuals with EDS in terms of comfort, functionality, and usability.
Studientyp
Einschreibung (Geschätzt)
Kontakte und Standorte
Studienkontakt
- Name: Erika Lewis, PT, EdD
- Telefonnummer: 978-934-4405
- E-Mail: Erika_Lewis@uml.edu
Studieren Sie die Kontaktsicherung
- Name: Yuko Oda, MFA, BA
- Telefonnummer: 978-934-3490
- E-Mail: Yuko_Oda@uml.edu
Studienorte
-
-
Massachusetts
-
Lowell, Massachusetts, Vereinigte Staaten, 01854
- Rekrutierung
- UMass Lowell, Expanded Media Fabrication Lab
-
Kontakt:
- Anna McCarthy, BFA
- Telefonnummer: 978-934-4294
- E-Mail: Anna_McCarthy@uml.edu
-
Hauptermittler:
- Erika Lewis, PT, EdD
-
Hauptermittler:
- Yuko Oda, MFA, BA
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
- Erwachsene
- Älterer Erwachsener
Akzeptiert gesunde Freiwillige
Probenahmeverfahren
Studienpopulation
Beschreibung
Inclusion Criteria:
- English-speaking
- 21 or older
- Ehlers-Danlos syndrome
- wrist hypermobility
Exclusion Criteria:
- Under 21
- pregnant women
- prisoners
- non-English-speaking
- skin sensitivity
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
Kohorten und Interventionen
Gruppe / Kohorte |
Intervention / Behandlung |
|---|---|
|
Ehlers-Danlos Syndrome (EDS)
Individuals with EDS with symptoms of wrist subluxation or wrist dislocation causing limitation in participation in self-care and activities and social activities
|
Fabricate a Custom 3D scanned and 3D printed wrist-hand orthosis for a participant with EDS to measure the change in pain, number of daily wrist subluxation and change in participation in activities such as gardening and cooking.
The investigators will use participant feedback to customize the fit and design of the orthosis for maximum comfort and effectiveness.
The investigators are using HD (high definition) 3D scanning and 3D printing technology for a precise fit to prevent subluxation.
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Wrist Joint Stability
Zeitfenster: From enrollment to the end of intervention at 8 weeks
|
Change the frequency of daily wrist subluxations and dislocations over 8 weeks (0-100, lower number is better)
|
From enrollment to the end of intervention at 8 weeks
|
|
Change in Pain Rating in upper extremity for individuals with EDS
Zeitfenster: From enrollment to the end of the intervention at 8 weeks
|
Change in pain as measured by the pain rating on the Health Assessment Questionnaire (HAQ-DI) (0-100 where 0=no pain and 100 = severe pain.
Lower number is better)
|
From enrollment to the end of the intervention at 8 weeks
|
|
Change in Activity Participation for individuals with EDS
Zeitfenster: From enrollment to the end of intervention at 8 weeks
|
Change in participation in daily activities, as indicated by improvements in the Health Assessment Questionnaire (HAQ-DI) (The 8 scores of the 8 sections are summed and divided by 8.
The result is the DI or FDI, the disability index or functional disability index.
Each question can be rated 0-3 with 0 representing better functional ability.)
|
From enrollment to the end of intervention at 8 weeks
|
|
Satisfaction of person with EDS with 3D Scanned and 3D printed orthosis
Zeitfenster: From Enrollment to the end of intervention at 8 weeks
|
Change in satisfaction levels as measured by the OPUS Satisfaction with Device and Services survey Satisfaction With Device Score is the sum of the scores for items 1-11 (11 - 55).
We will not use the "Satisfaction With Services Score is the sum of the scores for items 12-21 (10 - 50)".
The higher the score the better the outcome
|
From Enrollment to the end of intervention at 8 weeks
|
Mitarbeiter und Ermittler
Sponsor
Mitarbeiter
Ermittler
- Hauptermittler: Erika S Lewis, PT, EdD, University of Massachusetts, Lowell
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn (Tatsächlich)
Primärer Abschluss (Geschätzt)
Studienabschluss (Geschätzt)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Tatsächlich)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Tatsächlich)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
- Erkrankungen des Bewegungsapparates
- Gefäßerkrankungen
- Herz-Kreislauf-Erkrankungen
- Wunden und Verletzungen
- Gelenkerkrankungen
- Genetische Krankheiten, angeboren
- Bindegewebserkrankungen
- Hämatologische Erkrankungen
- Hautkrankheiten
- Angeborene Anomalien
- Hämostasestörungen
- Hämorrhagische Störungen
- Hautkrankheiten, genetisch
- Hautanomalien
- Kollagenerkrankungen
- Angeborene, erbliche und neonatale Krankheiten und Anomalien
- Haut- und Bindegewebserkrankungen
- Hämische und lymphatische Krankheiten
- Gelenkluxationen
- Ehlers-Danlos-Syndrom
- Ehlers-Danlos-Syndrom Typ 3
Andere Studien-ID-Nummern
- 23 (SIME)
Plan für individuelle Teilnehmerdaten (IPD)
Planen Sie, individuelle Teilnehmerdaten (IPD) zu teilen?
Beschreibung des IPD-Plans
IPD-Sharing-Zeitrahmen
IPD-Sharing-Zugriffskriterien
Art der unterstützenden IPD-Freigabeinformationen
- STUDIENPROTOKOLL
- SAFT
- ICF
- CSR
Arzneimittel- und Geräteinformationen, Studienunterlagen
Studiert ein von der US-amerikanischen FDA reguliertes Arzneimittelprodukt
Studiert ein von der US-amerikanischen FDA reguliertes Geräteprodukt
Produkt, das in den USA hergestellt und aus den USA exportiert wird
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .
Klinische Studien zur Ehlers-Danlos-Syndrom-Hypermobilitätstyp (hEDS)
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceAbgeschlossenEhlers-Danlos-Syndrom, vaskulärer TypFrankreich
-
Baylor College of MedicineBeendetHypermobiles Ehlers-Danlos-Syndrom | SchmerzbeurteilungVereinigte Staaten
-
Institut National de la Santé Et de la Recherche...Aktiv, nicht rekrutierend
-
Cambridge University Hospitals NHS Foundation TrustUniversity of CambridgeRekrutierungVaskuläres Ehlers-Danlos-Syndrom | Vaskuläres EDS (vEDS) | Vaskuläres Ehlers-Danlos-SyndromVereinigtes Königreich
-
Baylor College of MedicineSouthern Star Research Pty Ltd.RekrutierungVaskuläres Ehlers-Danlos-SyndromVereinigte Staaten
-
Aytu BioPharma, Inc.ParexelSuspendiertVaskuläres Ehlers-Danlos-SyndromVereinigte Staaten
-
Brigham and Women's HospitalNational Institutes of Health (NIH); Bernard Osher FoundationNoch keine RekrutierungHypermobiles EDS (hEDS) | Ehlers-Danlos-Syndrom (EDS) | Hypermobile SpektrumstörungVereinigte Staaten
-
University Health Network, TorontoAnmeldung auf EinladungHypermobiles Ehlers-Danlos-Syndrom | Ehlers-Danlos-Syndrom | Vaskuläres Ehlers-Danlos-Syndrom | Hypermobiles EDS (hEDS) | EDS | Klassisches Ehlers-Danlos-Syndrom | Klassisches EDS (cEDS) | Vaskuläres EDS (vEDS)Kanada
-
Acer Therapeutics Inc.RekrutierungVaskuläres Ehlers-Danlos-SyndromVereinigte Staaten
-
University Hospital, CaenAbgeschlossenEhlers-Danlos-Syndrom-Hypermobilitätstyp (hEDS)Frankreich